Informing the Drug Development and Commercialization Industry Cary, N.C. – January 31, 2012 – Industry Standard Research (ISR) today announced the release of two new reports focused on the biosimilar industry. “US Payers and Biosimilar Formulary Placement” and “Biosimilars: A View from the Pharmacy” expand the base of knowledge regarding biosimilar market dynamics. These reports … Continued
Informing the Drug Development and Commercialization Industry Cary, N.C. – January 17, 2012 – Industry Standard Research (ISR) today announced the release of a new report focused on the impact comparative effectiveness research (CER) is and will have on formulary placement. “US Payers: Comparative Effectiveness Research and formulary decision-making” looks at how US payers view … Continued
Cary, N.C. – January 11, 2012 – Industry Standard Research (ISR) today announced the availability of a new report titled”Electronic vs. In-person Detailing: A head-to-head comparison of Volume, Time, Value and Outcomes” that captures and compares product detail experiences from 118 Cardiologists, Oncologists, Family Practitioners, and Allergy / Immunologists. “The commonly held wisdom from both … Continued
Cary, N.C. – January 4, 2012 – Industry Standard Research (ISR) today announced the release of a new report titled “Clinical Imaging Market Dynamics and Service Provider Performance” in which 36 pharmaceutical sponsor decision-makers provide their usage, insights, and forecasts regarding the clinical imaging market by rating 98 service provider encounters. “The clinical imaging market … Continued
